Anavex Life Sciences Corp. (AVXL)
4.65
-0.11
(-2.31%)
USD |
NASDAQ |
Mar 06, 16:00
4.655
0.00 (0.00%)
After-Hours: 20:00
Anavex Life Sciences EPS Diluted (Quarterly) : -0.0638 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Nephros, Inc. | 0.0305 |
| Becton, Dickinson & Co. | 1.336 |
| Cabaletta Bio, Inc. | -0.4387 |
| ACADIA Pharmaceuticals, Inc. | 1.596 |
| Alnylam Pharmaceuticals, Inc. | 1.368 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -5.681M |
| Total Expenses (Quarterly) | 5.681M |
| Enterprise Value | 299.17M |
| Earnings Yield | -10.00% |
| Normalized Earnings Yield | -9.998 |